Atlas Trials

A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy.

Clinical trial NCT06050967 · COMPLETED

Trial details

NCT number
NCT06050967
Sponsor
Hadassah Medical Organization
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gaucher Disease Type 1
Start date
2022-04-01
Primary completion
2023-03-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.